Ken Griffin’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$179K Buy
+15,841
New +$179K ﹤0.01% 5045
2025
Q1
Sell
-136,493
Closed -$1.16M 6469
2024
Q4
$1.16M Buy
136,493
+9,244
+7% +$78.3K ﹤0.01% 3125
2024
Q3
$1.47M Buy
127,249
+108,427
+576% +$1.26M ﹤0.01% 2759
2024
Q2
$222K Sell
18,822
-68,262
-78% -$804K ﹤0.01% 4560
2024
Q1
$1.03M Sell
87,084
-696,614
-89% -$8.26M ﹤0.01% 3154
2023
Q4
$9.6M Sell
783,698
-144,804
-16% -$1.77M ﹤0.01% 1256
2023
Q3
$8.94M Buy
928,502
+81,896
+10% +$789K ﹤0.01% 1228
2023
Q2
$7.62M Buy
846,606
+718,211
+559% +$6.46M ﹤0.01% 1397
2023
Q1
$1.01M Buy
128,395
+26,868
+26% +$211K ﹤0.01% 3180
2022
Q4
$686K Sell
101,527
-37,995
-27% -$257K ﹤0.01% 3563
2022
Q3
$2.02M Sell
139,522
-33,759
-19% -$490K ﹤0.01% 2729
2022
Q2
$1.71M Buy
173,281
+110,311
+175% +$1.09M ﹤0.01% 2891
2022
Q1
$928K Buy
62,970
+45,564
+262% +$671K ﹤0.01% 3819
2021
Q4
$230K Sell
17,406
-23,256
-57% -$307K ﹤0.01% 5367
2021
Q3
$710K Sell
40,662
-35,186
-46% -$614K ﹤0.01% 4165
2021
Q2
$1.82M Buy
75,848
+30,437
+67% +$730K ﹤0.01% 3313
2021
Q1
$1.17M Buy
+45,411
New +$1.17M ﹤0.01% 3758
2020
Q4
Hold
0
5335
2020
Q2
Sell
-93,503
Closed -$715K 5009
2020
Q1
$715K Buy
+93,503
New +$715K ﹤0.01% 3132
2019
Q4
Sell
-10,194
Closed -$118K 4875
2019
Q3
$118K Sell
10,194
-10,878
-52% -$126K ﹤0.01% 4231
2019
Q2
$467K Buy
+21,072
New +$467K ﹤0.01% 3583
2016
Q3
Sell
-1,923
Closed -$18K 3808
2016
Q2
$18K Buy
+1,923
New +$18K ﹤0.01% 3227
2015
Q3
Sell
-279
Closed -$28K 4160
2015
Q2
$28K Buy
+279
New +$28K ﹤0.01% 3534